Molecular and cellular interactions between Brucella abortus antigens and host immune responses

Veterinary Microbiology

Volumn 90, Issue 1-4, 2002, Pages 417-424

  Oliveira, Sergio C ^a   Soeurt, Nancy ^b   Splitter, Gary ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Bacterial infection; Brucellosis; Cytokines; T cells

Indexed keywords

ANTIGEN; BACTERIAL PROTEIN; GENE PRODUCT; GREEN FLUORESCENT PROTEIN;

BACTERIAL GENE; BACTERIAL IMMUNITY; BACTERIAL SURVIVAL; BRUCELLA ABORTUS; BRUCELLOSIS; CELL STIMULATION; CELLULAR IMMUNITY; ESCHERICHIA COLI; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOBLOTTING; MUTAGENESIS; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; REVIEW; T LYMPHOCYTE; TH1 CELL;

BACTERIA (MICROORGANISMS); BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; ESCHERICHIA COLI;

EID: 0037146615     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(02)00225-0     Document Type: Article

References (39)

1. Al-Mariri A., Tibor A., Mertens P., De Bolle X., Michel P., Godefroid J., Walravens K., Letesson J.J. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect. Immun. 69:2001a;4816-4822.
2. Al-Mariri A., Tibor A., Mertens P., De Bolle X., Michel P., Godefroid J., Walravens K., Letesson J.J. Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp. Infect. Immun. 69:2001b;6264-6270.
3. Araya L.N., Winter A.J. Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum. Infect. Immun. 58:1990;254-256.
4. Bachrach G., Banai M., Bardenstein S., Hoida G., Bercovier H. Brucella ribosomal protein L7/L12 is a major component in the antigenicity of Brucellin INRA for delayed-type hypersensitivity in Brucella-sensitized guinea pigs. Infect. Immun. 62:1994;5361-5366.
5. Balaban N., Waithaka H.K., Njogu A.R., Goldman R. Intracellular antigens (microtubule-associated protein copurified with glycosomal enzymes) - possible vaccines against trypanosomiasis. J. Infect. Dis. 172:1995;845-850.
6. Brooks-Worrell B.M., Splitter G.A. Sodium dodecyl sulfate- and salt-extracted antigens from various Brucella species induce proliferation of bovine lymphocytes. Infect. Immun. 60:1992a;2136-2138.
7. Brooks-Worrell B.M., Splitter G.A. Antigens of Brucella abortus S19 immunodominant for bovine lymphocytes as identified by one- and two-dimensional cellular immunoblotting. Infect. Immun. 60:1992b;2459-2464.
8. Cespedes S., Andrews E., Folch H., Onate A. Identification and partial characterisation of a new protective antigen of Brucella abortus. J. Med. Microbiol. 49:2000;165-170.
9. Chirhart-Gilleland R.L., Kovach M.E., Elzer P.H., Jennings S.R., Roop R.M. II Identification and characterization of a 14-kilodalton Brucella abortus protein reactive with antibodies from naturally and experimentally infected hosts and T lymphocytes from experimentally infected BALB/c mice. Infect. Immun. 66:1998;4000-4003.
10. Corbel M.J. The immunogenic activity of ribosomal fractions derived from Brucella abortus. J. Hyg. (London). 76:1976;65-74.
11. Corbel M.J. Brucellosis: an overview. Emerg. Infect. Dis. 3:1997;213-221.
12. Denoël P.A., Vo T.K., Weynants V.E., Tibor A., Gilson D., Zygmunt M.S., Limet J.N., Letesson J.J. Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB. J. Med. Microbiol. 46:1997;801-806.
13. Dessein A.J., Begley M., Demeure C., Caillol D., Fueri J., dos Reis M.G., Andrade Z.A., Prata A., Bina J.C. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. J. Immunol. 140:1988;2727-2736.
14. Eskra L., Canavessi A., Carey M., Splitter G. Brucella abortus genes identified following constitutive growth and macrophage infection. Infect. Immun. 69:2001;7736-7742.
15. Foulongne V., Bourg G., Cazevieille C., Michaux-Charachon S., O'Callaghan D. Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis. Infect. Immun. 68:2000;1297-1303.
16. Golding B., Scott D.E., Scharf O., Huang L.Y., Zaitseva M., Eller N., Golding H. Immunity and protection against Brucella abortus. Microbes Infect. 3:2001;43-48.
17. Gregory R.L. Microbial ribosomal vaccines. Rev. Infect. Dis. 8:1986;208-217.
18. Heinrich K., Ryder M.H., Murphy P.J. Early production of rhizopine in nodules induced by Sinorhizobium meliloti strain L5-30. Can. J. Microbiol. 47:2001;165-171.
19. Hong P.C., Tsolis R.M., Ficht T.A. Identification of genes required for chronic persistence of Brucella abortus in mice. Infect. Immun. 68:2000;4102-4107.
20. Huang L.Y., Reis e Sousa C., Itoh Y., Inman J., Scott D.E. IL-12 induction by a TH1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10. J. Immunol. 167:2001;1423-1430.
21. Jungblut P.R., Grabher G., Stoffler G. Comprehensive detection of immunorelevant Borrelia garinii antigens by two-dimensional electrophoresis. Electrophoresis. 20:1999;3611-3622.
22. Kitaura H., Kinomoto M., Yamada T. Ribosomal protein L7 included in tuberculin purified protein derivative (PPD) is a major heat-resistant protein inducing strong delayed-type hypersensitivity. Scand. J. Immunol. 50:1999;580-587.
23. Kohler S., Ouahrani-Bettache S., Layssac M., Teyssier J., Liautard J.P. Constitutive and inducible expression of green fluorescent protein in Brucella suis. Infect. Immun. 67:1999;6695-6697.
24. Lestrate P., Delrue R.M., Danese I., Didembourg C., Taminiau B., Mertens P., De Bolle X., Tibor A., Tang C.M., Letesson J.J. Identification and characterization of in vivo attenuated mutants of Brucella melitensis. Mol. Microbiol. 38:2000;543-551.
25. Murphy E.A., Sathiyaseelan J., Parent M.A., Zou B., Baldwin C.L. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology. 103:2001;511-518.
26. O'Callaghan D., Cazevieille C., Allardet-Servent A., Boschiroli M.L., Bourg G., Foulongne V., Frutos P., Kulakov Y., Ramuz M. A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis. Mol. Microbiol. 33:1999;1210-1220.
27. Oliveira S.C., Splitter G.A. Subcloning and expression of the Brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein. Infect. Immun. 62:1994;5201-5204.
28. Oliveira S.C., Splitter G.A. CD8+ type 1 CD44hi CD45Rblo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and Class II-deficient mice. Eur. J. Immunol. 25:1995;2551-2557.
29. Oliveira S.C., Splitter G.A. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine. 14:1996;959-962.
30. Oliveira S.C., Zhu Y., Splitter G.A. Recombinant L7/L12 ribosomal protein and g irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells. Immunology. 83:1994;659-664.
31. Oliveira S.C., Harms J.S., Banai M., Splitter G.A. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs. Cell. Immunol. 15:1996;262-268.
32. Onate A.A., Vemulapalli R., Andrews E., Schurig G.G., Boyle S., Folch H. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. Abortus. Infect. Immun. 67:1999;986-988.
33. Pitarch A., Pardo M., Jimenez A., Pla J., Gil C., Sanchez M., Nombela C. Two-dimensional gel electrophoresis as analytical tool for identifying Candida albicans immunogenic proteins. Electrophoresis. 20:1999;1001-1010.
34. Rosinha G.M., Miyoshi A., Azevedo V., Splitter G.A., Oliveira S.C. Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administrated with an interleukin-12-expressing plasmid in a DNA vaccine formulation. J. Med. Microbiol. 51:2002;661-671.
35. Sieira R., Comerci D.J., Sanchez D.O., Ugalde R.A. A homologue of an operon required for DNA transfer in Agrobacterium is required in Brucella abortus for virulence and intracellular multiplication. J. Bacteriol. 182:2000;4849-5485.
36. Vemulapalli R., Duncan A.J., Boyle S.M., Sriranganathan N., Toth T.E., Schurig G.G. Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51. Infect. Immun. 66:1998;5684-5691.
37. Young E.J. Human brucellosis. Rev. Infect. Dis. 5:1983;821-842.
38. Zhan Y., Yang J.I., Cheers C. Cytokines response of T-cell subsets from Brucella abortus infected mice to soluble Brucella proteins. Infect. Immun. 61:1993;2841-2847.
39. Zhu Y., Oliveira S.C., Splitter G.A. Isolation of Brucella abortus ssb and uvrA genes from a genomic library by use of lymphocytes as probes. Infect. Immun. 61:1993;5339-5344.